NLRP3 and cardiac hypertrophy: In present study, we find that dysfunction of mitophagy may play an important role in pressure overload-induced cardiac hypertrophy, and semaglutide ameliorates this type of cardiac hypertrophy by improving mitophagy to suppress the activation of NLRP3 inflammasome.